Callodine Capital Management, LP Gilead Sciences, Inc. Transaction History

Callodine Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $2.32 Million - $2.9 Million	-40,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $2.6 Million - $2.95 Million	-40,000 Reduced 50.0%	40,000 $2.9 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $4.06 Million - $4.38 Million	-60,000 Reduced 42.86%	80,000 $5.59 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $3.49 Million - $3.81 Million	55,000 Added 64.71%	140,000 $9.64 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $5.1 Million - $5.82 Million	85,000 New	85,000 $5.49 Million

1,963

995M

10.5M

9.86M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $122B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Callodine Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Callodine Capital Management, LP with notifications on news.